Causal Relationship Between Helicobacter Pylori Antibodies and Immune Thrombocytopenia: A Mendelian Randomization Study

Overview

Journal Mediterr J Hematol Infect Dis

Date 2025 Jan 20

PMID 39830794

Authors

Yuzhan Chen

Qitian Mu

Guifang Ouyang

Affiliations

Soon will be listed here.

Abstract

Background: Previous observational studies have suggested a potential causal relationship between Helicobacter pylori () infection and immune thrombocytopenia (ITP). However, the evidence for causal inference remains contentious, and the underlying mechanisms require further investigation. To delve deeper into the relationship between and ITP, we conducted a Mendelian randomization (MR) analysis.

Method: In this study, we used two-sample Mendelian Randomization (MR) to assess the causality of seven different specific protein antibodies targeting on ITP. 76 single nucleotide polymorphisms (SNPs) related to antibody levels were obtained from the European Bioinformatics Institute (EBI). Summary data on ITP was obtained from the FinnGen database, and inverse variance weighted (IVW) analysis was identified as our main method. The reliability of the findings was ensured by performing many sensitivity analyses.

Result: Genetically predicted serum levels of GroEL antibodies were positively associated with an increased risk of ITP (odds ratio [OR] = 1.802, 95% CI 1.106-2.936, = 0.01799). No causal relationship was found between other antibodies and ITP.

Conclusion: The outcomes derived from our two-sample Mendelian randomization analysis demonstrate a discernible link between the levels of GroEL antibodies and an augmented susceptibility to ITP. However, it is imperative to expand the sample size further in order to corroborate the correlation between infection and ITP.

References

Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T . Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A. 2002; 99(22):14428-33. PMC: 137900. DOI: 10.1073/pnas.222375399. View

Arnold D, Bernotas A, Nazi I, Stasi R, Kuwana M, Liu Y . Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica. 2009; 94(6):850-6. PMC: 2688577. DOI: 10.3324/haematol.2008.005348. View

Stasi R, Sarpatwari A, Segal J, Osborn J, Evangelista M, Cooper N . Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2008; 113(6):1231-40. DOI: 10.1182/blood-2008-07-167155. View

Chmiela M, Jarosinska A, Rudnicka W . Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections. Cell Immunol. 2000; 202(2):136-9. DOI: 10.1006/cimm.2000.1654. View

Guo D, Chen Q, Wang G, Li C . Causal relationship between gut microbiota and immune thrombocytopenia: a Mendelian randomization study of two samples. Front Microbiol. 2023; 14:1190866. PMC: 10702357. DOI: 10.3389/fmicb.2023.1190866. View

Stasi R, Cooper N, Del Poeta G, Stipa E, Evangelista M, Abruzzese E . Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood. 2008; 112(4):1147-50. DOI: 10.1182/blood-2007-12-129262. View

Kurki M, Karjalainen J, Palta P, Sipila T, Kristiansson K, Donner K . FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023; 613(7944):508-518. PMC: 9849126. DOI: 10.1038/s41586-022-05473-8. View

Rudi J, Kolb C, Maiwald M, Kuck D, Sieg A, Galle P . Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol. 1998; 36(4):944-8. PMC: 104665. DOI: 10.1128/JCM.36.4.944-948.1998. View

Emdin C, Khera A, Kathiresan S . Mendelian Randomization. JAMA. 2017; 318(19):1925-1926. DOI: 10.1001/jama.2017.17219. View

10.

Guo C, Chu X, Shi Y, He W, Li L, Wang L . Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura. J Clin Immunol. 2007; 27(6):557-62. DOI: 10.1007/s10875-007-9111-1. View

11.

Rostami N, Keshtkar-Jahromi M, Rahnavardi M, Keshtkar-Jahromi M, Esfahani F . Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial. Am J Hematol. 2008; 83(5):376-81. DOI: 10.1002/ajh.21125. View

12.

Najaoui A, Bakchoul T, Stoy J, Bein G, Rummel M, Santoso S . Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP). Eur J Haematol. 2011; 88(2):167-74. DOI: 10.1111/j.1600-0609.2011.01718.x. View

13.

Moulinet T, Moussu A, Pierson L, Pagliuca S . The many facets of immune-mediated thrombocytopenia: Principles of immunobiology and immunotherapy. Blood Rev. 2023; 63:101141. DOI: 10.1016/j.blre.2023.101141. View

14.

DuBois S, Kearney D . Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence. Am J Gastroenterol. 2005; 100(2):453-9. DOI: 10.1111/j.1572-0241.2005.30252.x. View

15.

Zufferey A, Kapur R, Semple J . Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP). J Clin Med. 2017; 6(2). PMC: 5332920. DOI: 10.3390/jcm6020016. View

16.

Huang C, Chen Y, Chang J, Wu Y, Chen W, Wang Y . The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia. Mediterr J Hematol Infect Dis. 2023; 15(1):e2023030. PMC: 10171212. DOI: 10.4084/MJHID.2023.030. View

17.

van Doorn L, Figueiredo C, Megraud F, Pena S, Midolo P, Queiroz D . Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology. 1999; 116(4):823-30. DOI: 10.1016/s0016-5085(99)70065-x. View

18.

Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y . Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2003; 124(1):91-6. DOI: 10.1046/j.1365-2141.2003.04735.x. View

19.

Crowe S . Infection. N Engl J Med. 2019; 380(12):1158-1165. DOI: 10.1056/NEJMcp1710945. View

20.

Perez-Perez G, Bhat N, Gaensbauer J, Fraser A, Taylor D, Kuipers E . Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections. Int J Cancer. 1997; 72(3):453-6. DOI: 10.1002/(sici)1097-0215(19970729)72:3<453::aid-ijc13>3.0.co;2-d. View